NTRA · Healthcare
Natera Inc
37/100
Smart-money confidence1 of 3 sources positive
Weak — few signals
company insiders are selling
Hedge funds
65
Congress
No data
Insiders
0
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$44.7B
Industry
Diagnostics & Research
Sector
Healthcare
Exchange
NasdaqGS
About NATERA INC
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a…
Who's behind the signal
Every informed buyer we can see on NTRA, across all three feeds.
Hedge funds · 11
Duquesne Family Office (Druckenmiller)
Increased +22%
D.E. Shaw & Co
Increased +160%
AQR Capital Management
Increased +3%
Point72 (Steve Cohen)
Increased +254%
Gotham Asset Mgmt (Greenblatt)
Increased +10%
Citadel Advisors
Increased +138%
+5 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
Company insiders
Selling
Recent sells235
Congressional trades · 3 on record
Disclosures from 2023-03-06 to 2024-11-20
The newest disclosure we hold for this stock is 2024-11-20.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2024-11-20 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2023-04-10 | Daniel S. Goldman · D-NY | House | Sold | $1,001 - $15,000 |
| 2023-03-06 | Daniel S. Goldman · D-NY | House | Bought | $1,001 - $15,000 |
Not a model pick — but on our radar.
NATERA INC isn't in the top-10 model right now, but 11 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
11
Investors
0
New positions
6
Increasing
4
Decreasing
1
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.6×
% of portfolio
20.9%
Position change
+22%
20.9% of Duquesne Family Office's portfolio
Trust weight: 1.0×
% of portfolio
0.2%
Position change
+160%
0.2% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.2%
Position change
+3%
0.2% of AQR Capital Management's portfolio
Trust weight: 1.1×
% of portfolio
0.2%
Position change
+254%
0.2% of Point72's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+10%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+138%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.4×
% of portfolio
1.4%
Position change
—
1.4% of Coatue Management's portfolio
Trust weight: 1.3×
% of portfolio
1.1%
Position change
−6%
1.1% of ARK Invest's portfolio
Trust weight: 1.2×
% of portfolio
0.2%
Position change
−44%
0.2% of Tudor Investment's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−36%
0.0% of Millennium Management's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
−76%
0.0% of Bridgewater Associates's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to NATERA INC
0 buys and
235 sells
recorded in the last 90 days, but this stock's
per-transaction detail hasn't been fetched yet — only the totals.
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell NATERA INC or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime